These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 36555579)

  • 1. The Impact of Cytokines in Coronary Atherosclerotic Plaque: Current Therapeutic Approaches.
    Tsioufis P; Theofilis P; Tsioufis K; Tousoulis D
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
    Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Colchicine in Acute Coronary Syndromes.
    Vaidya K; Martínez G; Patel S
    Clin Ther; 2019 Jan; 41(1):11-20. PubMed ID: 30185392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hegemony of inflammation in atherosclerosis and coronary artery disease.
    Attiq A; Afzal S; Ahmad W; Kandeel M
    Eur J Pharmacol; 2024 Mar; 966():176338. PubMed ID: 38242225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview.
    Nidorf SM; Thompson PL
    Clin Ther; 2019 Jan; 41(1):41-48. PubMed ID: 30591286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes.
    Dimitroglou Y; Aggeli C; Theofilis P; Tsioufis P; Oikonomou E; Chasikidis C; Tsioufis K; Tousoulis D
    Life (Basel); 2023 Jul; 13(8):. PubMed ID: 37629526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Colchicine in Coronary Artery Disease.
    Butt AK; Cave B; Maturana M; Towers WF; Khouzam RN
    Curr Probl Cardiol; 2021 Mar; 46(3):100690. PubMed ID: 32994053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.
    Moreira DM; da Silva RL; Vieira JL; Fattah T; Lueneberg ME; Gottschall CA
    Am J Cardiovasc Drugs; 2015 Feb; 15(1):1-11. PubMed ID: 25369900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Colchicine in Atherosclerotic Cardiovascular Disease.
    Kurup R; Galougahi KK; Figtree G; Misra A; Patel S
    Heart Lung Circ; 2021 Jun; 30(6):795-806. PubMed ID: 33461916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colchicine and plaque: A focus on atherosclerosis imaging.
    Aldana-Bitar J; Golub IS; Moore J; Krishnan S; Verghese D; Manubolu VS; Benzing T; Ichikawa K; Hamal S; Kianoush S; Anderson LR; Ramirez NR; Leipsic JA; Karlsberg RP; Budoff MJ
    Prog Cardiovasc Dis; 2024; 84():68-75. PubMed ID: 38423236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
    Martínez GJ; Celermajer DS; Patel S
    Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid.
    Chapman MJ; Zamorano JL; Parhofer KG
    Pharmacol Ther; 2022 Sep; 237():108172. PubMed ID: 35304222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-inflammatory Cytokines in Acute Coronary Syndromes.
    Mourouzis K; Oikonomou E; Siasos G; Tsalamadris S; Vogiatzi G; Antonopoulos A; Fountoulakis P; Goliopoulou A; Papaioannou S; Tousoulis D
    Curr Pharm Des; 2020; 26(36):4624-4647. PubMed ID: 32282296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of Atherosclerosis.
    Kottoor SJ; Arora RR
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):483-493. PubMed ID: 29783850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the residual cardiovascular risk by specific anti-inflammatory interventions as a therapeutic strategy in atherosclerosis.
    Hafiane A; Daskalopoulou SS
    Pharmacol Res; 2022 Apr; 178():106157. PubMed ID: 35257900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory Therapeutics and Coronary Artery Disease.
    Eghtedari B; Roy SK; Budoff MJ
    Cardiol Rev; 2023 Mar-Apr 01; 31(2):80-86. PubMed ID: 35471811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine in ischemic heart disease: the good, the bad and the ugly.
    D'Amario D; Cappetta D; Cappannoli L; Princi G; Migliaro S; Diana G; Chouchane K; Borovac JA; Restivo A; Arcudi A; De Angelis A; Vergallo R; Montone RA; Galli M; Liuzzo G; Crea F
    Clin Res Cardiol; 2021 Oct; 110(10):1531-1542. PubMed ID: 33713178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colchicine in Stable Coronary Artery Disease.
    Fiolet ATL; Nidorf SM; Mosterd A; Cornel JH
    Clin Ther; 2019 Jan; 41(1):30-40. PubMed ID: 30396516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticytokine Immune Therapy and Atherothrombotic Cardiovascular Risk.
    Ait-Oufella H; Libby P; Tedgui A
    Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1510-1519. PubMed ID: 31294625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-Dependent Association of Inflammatory Cytokines with Carotid Atherosclerosis in Transient Ischaemic Attack: Implications for Clinical Trials.
    Coveney S; McCabe JJ; Murphy S; Belton O; Gray C; Cassidy T; Dolan E; de Gaetano M; Harbison J; Horgan G; Marnane M; Merwick A; Noone I; Williams DJ; Kelly PJ
    Cerebrovasc Dis; 2022; 51(2):178-187. PubMed ID: 34496366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.